We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BREW
2651
DELISTED
Craft Brew Alliance, Inc.
BREW
| $198K | ﹤0.01% |
14,832
+538
| +4% | +$8.02K |
|
|
STML
2652
DELISTED
Stemline Therapeutics, Inc.
STML
| $197K | ﹤0.01% |
23,078
+3,847
| +20% | +$35.1K |
|
|
MRT
2653
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $196K | ﹤0.01% |
17,474
+6,911
| +65% | +$77.1K |
|
|
REIS
2654
DELISTED
Reis, Inc.
REIS
| $196K | ﹤0.01% |
10,924
+412
| +4% | +$8.02K |
|
|
ENOC
2655
DELISTED
EnerNOC, Inc.
ENOC
| $195K | ﹤0.01% |
32,557
+1,129
| +4% | +$6.42K |
|
2656
Donegal Group Class A
DGICA
$719M
| $194K | ﹤0.01% |
11,012
+392
| +4% | +$6.64K |
|
2657
MediciNova
MNOV
$65.5M
| $194K | ﹤0.01% |
32,408
+1,392
| +4% | +$8.39K |
|
|
CFMS
2658
DELISTED
Conformis, Inc. Common Stock
CFMS
| $192K | ﹤0.01% |
1,471
+53
| +4% | +$8.97K |
|
2659
FreightCar America
RAIL
$264M
| $191K | ﹤0.01% |
15,277
+568
| +4% | +$7.95K |
|
2660
DMC Global
BOOM
$136M
| $190K | ﹤0.01% |
15,298
+657
| +4% | +$9.86K |
|
|
ORM
2661
DELISTED
Owens Realty Mortgage, Inc.
ORM
| $190K | ﹤0.01% |
10,663
+470
| +5% | +$8.12K |
|
|
HCCI
2662
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $189K | ﹤0.01% |
13,772
+673
| +5% | +$9.8K |
|
2663
TechTarget
TTGT
$322M
| $188K | ﹤0.01% |
20,855
+735
| +4% | +$6.51K |
|
|
RST
2664
DELISTED
ROSETTA STONE INC
RST
| $186K | ﹤0.01% |
19,057
+902
| +5% | +$7.59K |
|
|
MXWL
2665
DELISTED
Maxwell Technologies Inc
MXWL
| $186K | ﹤0.01% |
32,082
+1,480
| +5% | +$7.61K |
|
|
PHIIK
2666
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $186K | ﹤0.01% |
15,517
+174
| +1% | +$2.64K |
|
2667
Costamare
CMRE
$1.86B
| $185K | ﹤0.01% |
27,852
+2,860
| +11% | +$17.4K |
|
2668
Consolidated Water Co
CWCO
$471M
| $185K | ﹤0.01% |
15,917
+686
| +5% | +$7.24K |
|
2669
Tiptree Inc
TIPT
$656M
| $185K | ﹤0.01% |
25,371
+1,068
| +4% | +$7.01K |
|
2670
Standard BioTools
LAB
$348M
| $183K | ﹤0.01% |
32,202
+1,362
| +4% | +$8.63K |
|
|
RYZ
2671
Ryerson Holding Corp
RYZ
$1.46B
| $181K | ﹤0.01% |
14,399
+588
| +4% | +$6.68K |
|
|
TRVN
2672
DELISTED
Trevena, Inc.
TRVN
| $181K | ﹤0.01% |
79
+6
| +8% | +$20.4K |
|
|
ARC
2673
DELISTED
ARC Document Solutions, Inc.
ARC
| $180K | ﹤0.01% |
52,134
+1,921
| +4% | +$8.64K |
|
|
MPX
2674
DELISTED
Marine Products Corp
MPX
| $179K | ﹤0.01% |
16,426
+386
| +2% | +$4.45K |
|
|
AVID
2675
DELISTED
Avid Technology Inc
AVID
| $179K | ﹤0.01% |
38,334
+1,509
| +4% | +$7.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.